The complex role of iNOS in acutely rejecting cardiac transplants

Free Radical Biology and Medicine

Volumn 44, Issue 8, 2008, Pages 1536-1552

  Pieper, Galen M ^a   Roza, Allan M ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Free radicals; Graft rejection; Inducible nitric oxide synthase; Myocardium; Nitration; Nitric oxide; Peroxynitrite

Indexed keywords

4 AMINOBIOPTERIN; BIOPTERIN; CYCLOSPORIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; METALLOPROTEIN; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; PEROXYNITRITE; PTERIN DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; CELLULAR DISTRIBUTION; CHRONIC GRAFT REJECTION; CHRONOTROPISM; DRUG INHIBITION; DRUG MECHANISM; GENE DELETION; GRAFT REJECTION; GRAFT SURVIVAL; HEART FUNCTION; HEART TRANSPLANTATION; HUMAN; NITRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW;

ACUTE DISEASE; ANIMALS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PEROXYNITROUS ACID;

RODENTIA;

EID: 41149091086     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.01.020     Document Type: Review

References (149)

1. Gotts W.G., and Johnson M.R. The challenge of rejection and cardiac allograft vasculopathy. Heart Fail. Rev. 6 (2001) 227-240
2. Kriett J.M., and Kaye M.P. The registry of the International Society for Heart Transplantation: seventh office report. J. Heart Lung Transplant. 9 (1990) 323-330
3. Billingham M.E., Cary N.R., Hamond M.E., Kemnitz J., Marboe C., McCallister H.A., Snovar D.C., Winters G.L., and Zerbe A. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J. Heart Transplant. 9 (1990) 587-593
4. Stewart S., Winters G.L., Fishbein M.C., Tazelaar H.D., Kobashigawa J., Abrams J., Andersen C.B., Angelini A., Berry G.J., Burke M.M., Demetris A.J., Hammond E., Itescu S., Marboe C.C., McManus B., Reed E.F., Reinsmoen N.L., Rodriguez E.R., Rose A.G., Rose M., Suciu-Focia N., Zeevi A., and Billingham M.E. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J. Heart Lung Transplant. 24 (2005) 1710-1720
5. Stoica S.C., Cafferty F., Pauriah M., Taylor C.J., Sharples L.D., Wallwork J., Large S.R., and Parameshwar J. The cumulative effect of acute rejection on development of cardiac allograft vasculopathy. J. Heart Lung Transplant. 25 (2006) 420-425
6. Halloran P.F. The immune response to an organ transplant. In: Wood K. (Ed). Handbook of transplant immunology (1995), MedSci Publ., Stokes Pages, Buckinghamshire, UK 223
7. Nagano H., Nadeau K.C., Takada M., Kusaka M., and Tilney N.L. Sequential cellular and molecular kinetics in acutely rejecting renal allografts in rats. Transplantation 63 (1997) 1101-1108
8. Yang X., Chowdhury N., Cai B., Brett J., Marboe C., Sciacca R.R., Michler M.E., and Cannon P.J. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J. Clin. Invest. 94 (1994) 714-721
9. Shiraishi T., DeMeester S.R., Worrall N.K., Ritter J.H., Misko T.P., Ferguson Jr. T.B., Cooper J.D., and Patterson G.A. Inhibition of inducible nitric oxide synthase ameliorates rat lung allograft rejection. J. Thorac. Cardiovasc. Surg. 110 (1995) 1449-1460
10. Worrall N.K., Boasquevisque C.H., Botney M.D., Misko T.P., Sullivan P.M., Ritter J.H., Ferguson Jr. T.B., and Patterson G.A. Inhibition of inducible nitric oxide synthase ameliorates functional and histological changes of acute lung allograft rejection. Transplantation 63 (1997) 1095-1101
11. Vos I.H.C., Joles J.A., Schurink M., Weckbecker G., Stojanovic T., Rabelink T.J., and Gröne H.J. Inhibition of inducible nitric oxide synthase improves graft function and reduces tubulointerstitial injury in renal allograft rejection. Eur. J. Pharmacol. 391 (2000) 31-38
12. Stevens R.B., Ansite J.D., Mills C.D., Lokeh A., Rossini R.J., Saxena M., Brown R.R., and Sutherland D.E.R. Nitric oxide mediates early dysfunction of rat and mouse islets after transplantation. Transplantation 61 (1996) 1740-1749
13. Brandhorst D., Brandhorst H., Zwolinski A., Nahidi F., and Bretzel R.G. Prevention of early islet graft failure by selective inducible nitric oxide synthase inhibitors after pig to nude rat intraportal islet transplantation. Transplantation 71 (2001) 179-184
14. Střeštiková P., Plšková J., Filipec M., and Farghali H. FK 506 and aminoguanidine suppress iNOS induction in orthotopic corneal allografts and prolong graft survival in mice. Nitric Oxide 9 (2003) 111-117
15. Ouyang J., Xu D., Zhang X., Qi S., Ma A., Jiang W., Chida N., Sudo Y., Tamura K., Daloze P., and Chen H. Effect of a novel inducible nitric oxide synthase inhibitor in prevention of rat chronic aortic rejections. Transplantation 79 (2005) 1386-1392
16. Perrault L.P., Bidouard J.P., Janiak P., Villeneuve N., Bruneval P., Villaine J.P., and Vanhoutte P.M. Time course of coronary endothelial dysfunction in acute untreated rejection after heterotopic heart transplantation. J. Heart Lung Transplant. 16 (1997) 643-657
17. Demers P., Elkouri S., Sirois M.G., and Cartier R. Coronary artery endothelial dysfunction after ischemia-reperfusion and acute untreated rejection in a canine heterotopic heart transplantation model. Transplantation 71 (2001) 26-32
18. Vejlstrup N.G., Andersen C.B., Boesgaard S., Mortensen S.A., and Aldershvile J. Temporal changes in myocardial endothelial nitric oxide synthase expression following human heart transplantation. J. Heart Lung Transplant. 21 (2002) 211-216
19. Wildhirt S.M., Weis M., Schulze C., Conrad N., Pehlivanli S., Rieder G., Enders G., von Scheidt W., and Reichart B. Expression of endomyocardial nitric oxide synthase and coronary endothelial function in human cardiac allografts. Circulation 104 Suppl. I (2001) 336-343
20. Wildhirt S.M., Weis M., Schulze C., Conrad N., Pehlivanli S., Rieder G., Enders G., von Scheidt W., and Reichart B. Coronary flow reserve and nitric oxide synthases after cardiac transplantation in humans. Eur. J. Cardio-Thorac. Surg. 19 (2001) 840-847
21. Lee P.C., Wang Z.L., Mahidhara R., Qian S., Watkins S.C., Griffith B.P., Billiar T.R., and Shears II L.L. Inducible nitric oxide synthase attenuates acute cardiac rejection. J. Am. Coll. Surg. 191 (2000) S98-S99
22. Yap J., O'Brien T., Pellegrini C., Barber D.A., Tazelaar H.D., Severson S.R., Miller V.M., and McGregor C.G.A. Distribution and function of recombinant endothelial nitric oxide synthase in transplanted hearts. Cardiovasc. Res. 42 (1999) 720-727
23. Iwata A., Sai S., Nitta Y., Chen M., de Fries-Hallstrand R., Dalesandro J., Thomas R., and Allen M.D. Liposome-mediated gene transfection of endothelial nitric oxide synthase reduces endothelial activation and leukocyte infiltration in transplanted hearts. Circulation 103 (2001) 2753-2759
24. Jeppsson A., Pellegrini C., O'Brien T., Miller J.M., Tazelaar H.D., Taner C.B., and McGregor C.G.A. Gene transfer of endothelial nitric oxide synthase to pulmonary allografts: impact on acute rejection. Transplant. Int. 13 Suppl. 1 (2000) S591-S596
25. Shears II L.L., Kawaharada N., Tzeng E., Billiar T.R., Watkins S.C., Kovesdi I., Lizonova A., and Pham S.M. Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis. J. Clin. Invest. 100 (1997) 2035-2042
26. Koglin J., Glysing-Jensen T., Mudgett J.S., and Russell M.E. NOS2 mediates opposing effects in models of acute and chronic cardiac rejection: insights from NOS2 knockout mice. Am. J. Pathol. 153 (1998) 1371-1376
27. Qian Z., Gelzer-Bell R., Yang S.X., Cao W., Ohnishi T., Wasowska B.A., Hruban R.H., Rodriguez E.R., Baldwin III W.M., and Lowenstein C.J. Inducible nitric oxide synthase inhibition of Weibel-Palade body release in cardiac transplant rejection. Circulation 104 (2001) 2369-2375
28. Du C., Jiang J., Guan Q., Diao H., Yin Z., Wang S., Zhong R., and Jevnikar A.M. NOS2 (iNOS) deficiency in kidney donor accelerates allograft loss in a murine model. Am. J. Transplant. 7 (2007) 17-26
29. Weis M., and Cooke J.P. Cardiac allograft vasculopathy and dysregulation of the NO synthase pathway. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 567-575
30. Minamoto K., and Pinsky D.J. Recipient iNOS but not eNOS deficiency reduces luminal narrowing in tracheal allografts. J. Exp. Med. 196 (2002) 1321-1333
31. Hosenpud J.D., Boyle T.M., Hensler H., Sanford G., and Khanna A.K. The relationship between acute rejection and chronic rejection is highly dependent on specific MHC matching: a multi-strain rat heterotopic heart transplant study. Transplantation 69 (2000) 2173-2178
32. Meier-Kriesche H.U., Ojo A.O., Hanson J.A., Cibrik D.M., Punch J.D., Leichtman A.B., and Kaplan B. Increased impact of acute rejection on chronic allograft failure in recent era. Transplantation 70 (2000) 1098-1100
33. Lewis N.P., Tsao P.S., Rickenbacher P.R., Xue C., Johns R.A., Haywood G.A., von der Leyen H., Trindale P.T., Cooke J.P., Hunt S.A., Billingham M.E., Valantine H.A., and Fowler M.B. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation 93 (1996) 720-729
34. Paulus W.J., Kästner S., Pujadas P., Shah A.M., Drexler H., and Vanderheyden M. Left ventricular contractile effects of inducible nitric oxide synthase in the human allograft. Circulation 96 (1997) 3436-3442
35. Winlaw D.S., Schyvens C.G., Smythe G.A., Du Z.Y., Rainer S.P., Lord R.S., Spratt P.M., and Macdonald P.S. Selective inhibition of nitric oxide production during cardiac allograft rejection causes a small increase in graft survival. Transplantation 60 (1995) 77-82
36. Menon S.G., Zhao L., Xu S., Samlowski W.E., Shelby J., McGregor J., and Barry W.H. Relative importance of cytotoxic T lymphocytes and nitric oxide-dependent cytotoxicity in contractile dysfunction of rejecting murine cardiac allografts. Transplantation 66 (1998) 413-419
37. w-monomethyl-l-arginine inhibits nitric oxide production in murine cardiac allografts but does not affect graft rejection. Biochim. Biophys. Acta 1226 (1994) 225-231
38. Yamamoto M., Maeda H., Hirose N., Radhakrishnan G., Katare R.G., Hayashi Y., Rao P., Lee G.H., Yamaguchi T., and Sasaguri S. Bilirubin oxidation provoked by nitric oxide radicals predicts the progression of acute cardiac allograft rejection. Am. J. Transplant. 7 (2007) 1897-1906
39. Paul L.C., Myllärniemi M., Muzaffar S., and Benediktsson H. Nitric oxide synthase inhibition is associated with decreased survival of cardiac allografts in the rat. Transplantation 62 (1996) 1193-1195
40. Komarov A., Mattson D., Jones M.M., Singh P.K., and Lai C.-S. In vivo spin trapping of nitric oxide in mice. Biochem. Biophys. Res. Commun. 195 (1993) 1191-1198
41. Komarov A.M., and Lai C.-S. Detection of nitric oxide production in mice by spin-trapping electron paramagnetic resonance spectroscopy. Biochim. Biophys. Acta 1272 (1995) 29-36
42. 2+ with diethyldithiocarbamate or N-methyl-d-glucamine dithiocarbamate as traps of nitric oxide in animal tissues: comparative investigations. Biochim. Biophys. Acta 1336 (1997) 225-234
43. Rochelle L.G., Morana S.J., Kruszyna H., Russell M.A., Wilcox D.E., and Smith R.P. Interactions between hydroxocobalamin and nitric oxide (NO): evidence for a redox reaction between NO and reduced cobalamin and reversible NO binding to oxidized cobalamin. J. Pharmacol. Exp. Ther. 275 (1995) 48-52
44. Greenberg S.S., Xie J., Zatarain J.M., Kapusta D.R., and Miller M.J.S. Hydroxocobalamin (vitamin B12a) prevents and reverses endotoxin-induced hypotension and mortality in rodents: role of nitric oxide. J. Pharmacol. Exp. Ther. 273 (1995) 257-265
45. Brouwer M., Chamulitrat W., Ferruzzi G., Sauls D.L., and Weinberg J.B. Nitric oxide interactions with cobalamins: biochemical and functional consequences. Blood 88 (1996) 1857-1864
46. Marmion C.J., Cameron B., Mulcahy C., and Fricker S.P. Ruthenium as an effective nitric oxide scavenger. Curr. Top. Med. Chem. 4 (2004) 1585-1603
47. Mosi R., Sequin B., Cameron B., Amankwa L., Darkes M.C., and Fricker S.P. Mechanistic studies on AMD6221: a ruthenium-based nitric oxide scavenger. Biochem. Biophys. Res. Commun. 292 (2002) 519-529
48. Cooper M., Lindholm P., Pieper G., Seibel R., Moore G., Nakanishi A., Dembny K., Komorowski R., Johnson C., Adams M., and Roza A. Myocardial nuclear factor-kB activity and nitric oxide production in rejecting cardiac allografts. Transplantation 66 (1998) 838-844
49. Nakanishi A.L., Roza A.M., Adams M.B., Seibel R., Moore-Hilton G., Kalyanaraman B., and Pieper G.M. Electron spin resonance analysis of heme-nitrosyl and reduced iron-sulfur centered complexes in allogeneic, heterotopic cardiac transplants: effects of treatment with pyrrolidine dithiocarbamate. Free Radic. Biol. Med. 25 (1998) 201-207
50. Roza A.M., Cooper M., Pieper G., Hilton G., Dembny K., Lai C.S., Lindholm P., Komorowski R., Felix C., Johnson C., and Adams M. NOX 100, a nitric oxide scavenger, enhances cardiac allograft survival and promotes long-term graft acceptance. Transplantation 69 (2000) 227-231
51. Pieper G.M., Adams M.B., Felix C.C., and Roza A.M. Role of nitric oxide in cardiac transplant rejection: documentation by EPR spectroscopy and other techniques. In: Gryglewksi R.J., and Minuz P. (Eds). Nitric oxide: basic research and clinical applications, Proceedings of the NATO Advanced Study Institute, September 7-17, 2000 (2001), IOS Press, Erice, Italy. Amsterdam 71-79
52. Pieper G.M., Khanna A.K., Kampalath B., Felix C.C., Hilton G., Johnson C.P., Adams M.B., and Roza A.M. Inhibition of nitrosylation, nitration, lymphocyte proliferation, and gene expression in acute and delayed cardiac allograft rejection by an orally active dithiocarbamate. J. Cardiovasc. Pharmacol. 43 (2004) 522-530
53. Pieper G.M., Roza A.M., Adams M.B., Hilton G., Johnson M., Felix C.C., Kampalath B., Darkes M., Wanggui Y., Cameron B., and Fricker S.P. A ruthenium (III) polyaminocarboxylate complex, a novel nitric oxide scavenger, enhances graft survival and decreases nitrosylated heme protein in models of acute and delayed transplant rejection. J. Cardiovasc. Pharmacol. 39 (2002) 441-448
54. Misko T.P., Moore W.M., Kasten T.P., Nickols G.A., Corbett J.A., Tilton R.G., McDaniel M.L., Williamson J.R., and Currie M.G. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol. 233 (1993) 119-125
55. Worrall N.K., Lazenby W.D., Misko T.P., Lin T.S., Rodi C.P., Manning P.T., and Ferguson Jr. T.B. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J. Exp. Med. 181 (1995) 63-70
56. Takahashi W., Suzuki J., Izawa A., Takayama K., Yamazaki S., and Isobe M. Inducible nitric oxide-mediated myocardial apoptosis contributes to graft failure during acute cardiac allograft rejection in mice. Jpn. Heart J. 41 (2000) 493-506
57. Soto P.F., Jia C.X., Rabkin D.G., Hart J.P., Carter Y.M., Sardo M.J., Hsu D.T., Fisher P.E., Pinsky D.J., and Spotnitz H.M. Improvement of rejection-induced diastolic abnormalities in rat cardiac allografts with inducible nitric oxide synthase inhibition. J. Thorac. Cardiovasc. Surg. 120 (2000) 39-46
58. Schuler W. Zur Hemming der Diamniooxylase (Histaminase). Experientia 8 (1952) 230-232
59. Kumari K., Umar S., Bansal V., and Sahib M.K. Inhibition of diabetes-associated complications by nucleophilic compounds. Diabetes 40 (1991) 1079-1084
60. Wani J., Carl M., Henger A., Nelson P.J., and Rupprecht H. Nitric oxide modulates expression of extracellular matrix genes linked to fibrosis in kidney mesangial cells. Biol. Chem. 388 (2007) 497-506
61. Ramana K.V., Willis M.S., White M.D., Horton J.W., DiMaio J.M., Srivastava D., Bhatnagar A., and Srivastava S.K. Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition. Circulation 114 (2006) 1838-1846
62. Ramana K.V., Reddy A.B.M., Tammali R., and Srivastava S.K. Aldose reductase mediates endotoxin-production of nitric oxide and cytotoxicity in murine macrophages. Free Radic. Biol. Med. 42 (2007) 1290-1302
63. Blasko E., Glaser C.B., Devlin J.J., Xia W., Feldman R.I., Polokoff M.A., Phillips G.B., Whitlow M., Auld D.S., McMillan K., Ghosh S., Stuehr D.J., and Parkinson J.F. Mechanistic studies with potent and selective inducible nitric-oxide synthase dimerization inhibitors. J. Biol. Chem. 277 (2002) 295-302
64. Szabolcs M.J., Sun J., Ma N., Albala A., Sciacca R.R., Philips G.B., Parkinson J., Edwards N., and Cannon P.J. Effects of selective inhibitors of nitric oxide synthase-2 dimerization on acute cardiac allograft rejection. Circulation 106 (2002) 2392-2396
65. Kolodziejski P.J., Koo J.S., and Eissa N.T. Regulation of inducible nitric oxide synthase by rapid cellular turnover and cotranslational down-regulation by dimerization inhibitors. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 18141-18146
66. 6-(1-iminoethyl)-l-lysine in acute cardiac transplant rejection. Am. J. Physiol., Heart Circ. Physiol. 286 (2004) H525-H534
67. Schmidt K., Werner-Felmayer G., Mayer B., and Werner E.R. Preferential inhibition of inducible nitric oxide synthase in intact cells by the 4-amino analogue of tetrahydrobiopterin. Eur. J. Biochem. 259 (1999) 25-31
68. Brandacher G., Zou Y., Obrist P., Steurer W., Werner-Felmayer G., Margreiter R., and Werner E.R. The 4-amino analogue of tetrahydrobiopterin efficiently prolongs murine cardiac-allograft survival. J. Heart Lung Transplant. 20 (2001) 747-749
69. Brandacher G., Maglione M., Schneeberger S., Obrist P., Thoeni G., Wrulich O.A., Werner-Felmayer G., Margreiter R., and Werner E.R. Tetrahydrobiopterin compounds prolong allograft survival independently of their effect on nitric oxide synthase activity. Transplantation 81 (2006) 583-589
70. Thoeni G., Stoitzner P., Brandacher G., Romani N., Heufler C., Werner-Felmayer G., and Werner E.R. Tetrahydro-4-aminobiopterin attenuates dendritic cell-induced T cell priming independently from inducible nitric oxide synthase. J. Immunol. 174 (2005) 7584-7591
71. -/- recipients correlates with reduced apoptosis. Circulation 99 (1999) 836-842
72. Mannon R.B., Roberts K., Ruiz P., Laubach V., and Coffmann T.M. Inducible nitric oxide synthase promotes cytokine expression in cardiac allografts but is not required for efficient rejection. J. Heart Lung Transplant. 18 (1999) 819-827
73. +/+ mice: effects of cellular chimeras on myocardial inflammation and cardiomyocyte damage and apoptosis. Circulation 103 (2001) 2514-2520
74. Most D., Efron D.T., Shi H.P., Tantry U.S., and Barbul A. Differential cytokine expression in skin graft healing in inducible nitric oxide knockout mice. Plast. Reconstr. Surg. 108 (2001) 1251-1259
75. Casey J.J., Wei X.Q., Orr D.J., Gracie J.A., Huang F.P., Bolton E.M., Liew F.Y., and Bradley J.A. Skin allograft rejection in mice lacking inducible nitric oxide synthase. Transplantation 64 (1997) 589-593
76. Huang A., Sun D., Shesely E.G., Levee E.M., Koller A., and Kaley G. Neuronal NOS-dependent dilation to flow in coronary arteries of male eNOS-KO mice. Am. J. Physiol., Heart Circ. Physiol. 282 (2002) H429-H436
77. Al-shabrawey M., El-Remessy A.B., Brooks S.S., Hamed M.S., Huang P., and Caldwell R.B. Normal vascular development in mice deficient in endothelial NO synthase: possible role of neuronal NO synthase. Mol. Vis. 9 (2003) 549-558
78. Biecker E., Neef M., Sägesser H., Shaw S., Koshy A., and Reichen J. Nitric oxide synthase 1 is partly compensating for nitric oxide synthase 3 deficiency in nitric oxide synthase 3 knock-out mice and is elevated in murine and human cirrhosis. Liver Int. 24 (2004) 345-353
79. Talukder M.A.H., Fujiki T., Morikawa K., Motoishi M., Kubota H., Morishita T., Tsutsui M., Takeshita A., and Shimokawa H. Up-regulated neuronal nitric oxide synthase compensates coronary flow response to bradykinin in endothelial nitric oxide synthase-deficient mice. J. Cardiovasc. Pharmacol. 44 (2004) 437-445
80. Henry Y., Lepoivre M., Drapier J.-C., Ducrocq C., Boucher J.-L., and Guissani A. EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J. 7 (1993) 1124-1134
81. Henry Y., and Guissani A. Interactions of nitric oxide with hemoproteins: roles of nitric oxide in mitochondria. Cell. Mol. Life Sci. 55 (1999) 1003-1014
82. Brown G.C. Nitric oxide inhibition of cytochrome oxidase and mitochondrial respiration: implications for inflammatory, neurodegenerative and ischaemic pathologies. Mol. Cell. Biochem. 174 (1997) 189-192
83. Lancaster Jr. J.R., Langrehr J.M., Bergonia H.A., Murase N., Simmons R.L., and Hoffman R.A. EPR detection of heme and nonheme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft. J. Biol. Chem. 267 (1992) 10994-10998
84. Pieper G.M. Protection against allograft rejection by iron-dithiocarbamate complexes. In: Van Faassen E., and Vanin A.F. (Eds). Radicals for life: the various forms of nitric oxide (2007), Elsevier, Amsterdam 407-422
85. Li H., Samouilov A., Liu X., and Zweier J.L. Characterization of the magnitude and kinetics of xanthine oxidase-catalyzed nitrite reduction: evaluation of its role in nitric oxide generation in anoxic tissues. J. Biol. Chem. 276 (2001) 24482-24489
86. Li H., Samouilov A., Liu X., and Zweier J.L. Characterization of the magnitude and kinetics of xanthine-oxidase catalyzed nitrate reduction: evaluation of its role in nitrite and nitric oxide generation in anoxic tissue. Biochemistry 42 (2003) 1150-1159
87. Lancaster Jr. J.R., and Hibbs Jr. J.B. EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 1223-1227
88. Pieper G.M., Halligan N.L.N., Hilton G., Konorev E.A., Felix C.C., Roza A.M., Adams M.B., and Griffith O.W. Non-heme iron protein: a potential target of nitric oxide in acute cardiac allograft rejection. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 3125-3130
89. Nilakantan V., Halligan N.L.N., Nguyen T.K., Hilton G., Khanna A.K., Roza A.M., Johnson C.P., Adams M.B., Griffith O.W., and Pieper G.M. Post-translational modification of manganese superoxide dismutase in acutely rejecting cardiac transplants: role of inducible nitric oxide synthase. J. Heart Lung Transplant. 24 (2005) 1591-1599
90. Bertolet B.D., Eagle D.A., Conti J.B., Mills Jr. R.M., and Belardinelli L. Bradycardia after heart transplantation: reversal with theophylline. J. Am. Coll. Cardiol. 28 (1996) 396-399
91. Chowdhary S., Ng A., Nuttall S.L., Coote J.H., Ross H.F., and Townend J.N. Nitric oxide and cardiac parasympathetic control in human heart failure. Clin. Sci. 102 (2002) 397-402
92. Chowdhary S., Marsh A.M., Coote J.H., and Townend J.N. Nitric oxide and cardiac muscarinic control in humans. Hypertension 43 (2004) 1023-1028
93. Chowdhary S., Harrington D., Bonser R.S., Coote J.H., and Townend J.N. Chronotropic effects of nitric oxide in the denervated human heart. J. Physiol. 541 (2002) 645-651
94. Pieper G.M., Nilakantan V., Halligan N.L.N., Khanna A.K., Hilton G., and Vásquez-Vivar J. Nitric oxide formation in acutely rejecting cardiac allografts correlates with GTP cyclohydrolase I activity. Biochem. J. 391 (2005) 541-547
95. Heger J., Gödecke A., Flögel U., Merx M.W., Molojavyi A., Kühn-Velten W.N., and Schrader J. Cardiac-specific overexpression of inducible nitric oxide synthase does not result in severe cardiac dysfunction. Circ. Res. 90 (2002) 93-99
96. Mungrue I.N., Gros R., You X., Pirani A., Azad A., Csont T., Schulz R., Butany J., Stewart D.J., and Husain M. Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J. Clin. Invest. 109 (2002) 735-743
97. Massion P.B., Feron O., Dessy C., and Balligand J.L. Nitric oxide and cardiac function: ten years after, and continuing. Circ. Res. 93 (2003) 388-398
98. Brady, A. J. B., Waren, J. B., Poole-Wilson, P. A., Williams, T. J., Harding, S. E., Nitric oxide attenuates cardiac myocyte contraction. Am. J. Physiol. 265 (Heart Circ. Physiol. 34):H176-H182,1993.
99. Joe E.K., Schussheim A.E., Longrois D., Mäki T., Kelly R.A., Smith T.W., and Balligand J.-L. Regulation of cardiac myocyte contractile function by inducible nitric oxide synthase (iNOS): mechanisms of contractile depression by nitric oxide. J. Mol. Cell. Cardiol. 30 (1998) 303-315
100. Tatsumi T., Matoba S., Kawahara A., Keira N., Shiraishi J., Akashi K., Kobara M., Tanaka T., Katamura M., Nakagawa C., Ohta B., Shirayama T., Takeda K., Asayama J., Fliss H., and Nakagawa M. Cytokine-induced nitric oxide production inhibits mitochondrial energy production and impairs contractile function in rat cardiac myocytes. J. Am. Coll. Cardiol. 35 (2000) 1338-1346
101. Wahler, G. M., Dollinger, S. J., Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase. Am. J. Physiol. 268 (Cell Physiol. 37):C45-C54, 1995.
102. Finkel M.S., Oddis C.V., Jacob T.D., Watkins S.C., Hattler B.G., and Simmons R.L. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257 (1992) 387-389
103. Kumar, A., Brar, R., Wang, P., Dee, L., Skorupa, G., Khadour, F., Schulz, R., Parrilo, J. E., Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. Am. J. Physiol. 276 (Regul. Integr. Comp. Physiol. 45):R265-R276, 1999.
104. Yokoyama T., Vaca L., Rossen R.D., Durante W., Hazarika P., and Mann D.L. Cellular basis for the negative inotropic effects of tumor necrosis factor-a in the adult mammalian heart. J. Clin. Invest. 92 (1993) 2303-2312
105. Stein B., Frank P., Schmitz W., Scholz H., and Thoenes M. Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. J. Mol. Cell. Cardiol. 28 (1996) 1631-1639
106. Grandel U., Fink L., Blum A., Heep M., Buerke M., Kraemer H.-J., Mayer K., Bohle R.M., Seeger W., Grimminger F., and Sibelius U. Endotoxin-induced myocardial tumor necrosis factor-a synthesis depresses contractility of isolated rat hearts: evidence for a role of sphingosine and cyclooxygenase-2-derived thromboxane production. Circulation 102 (2000) 2758-2764
107. Sugishita K., Kinugawa K., Shimizu T., Harada K., Matsui H., Takahashi T., Serizawa T., and Kohmoto O. Cellular basis for the acute inhibitory effects of IL-6 and TNF-a on excitation-contraction coupling. J. Mol. Cell. Cardiol. 31 (1999) 1457-1467
108. I homeostasis during early allogeneic heart transplant rejection. Transplantation 72 (2001) 1603-1607
109. Ziolo M.T., Dollinger S.J., and Wahler G.M. Myocytes isolated from rejecting transplanted rat hearts exhibit reduced basal shortening which is reversible by aminoguanidine. J. Mol. Cell. Cardiol. 30 (1998) 1009-1017
110. Pyo R.T., and Wahler G.M. Ventricular myocytes isolated from rejecting cardiac allografts exhibit a reduced b-adrenergic contractile response. J. Mol. Cell. Cardiol. 27 (1995) 773-776
111. Ziolo M.T., Harshbarger C.H., Roycroft K.E., Smith J.M., Romano F.D., Sondergroth K.L., and Wahler G.M. Myocytes isolated from rejecting transplanted rat hearts exhibit a nitric oxide-mediated reduction in the calcium current. J. Mol. Cell. Cardiol. 33 (2001) 1691-1699
112. Worrall, N. K., Pyo, R. T., Botney, M. D., Misko, T. P., Sullivan, P. M., Alexander, D. G., Lazenby, W. D., Ferguson, T. B., Inflammatory cell-derived NO modulates cardiac allograft contractile and electrophysiological function. Am. J. Physiol. 273 (Heart Circ. Physiol. 42):H28-H37, 1997.
113. Scherrer-Crosbie M., Glysing-Jensen T., Fry S.J., Vançon A.C., Gadiraju S., Picard M.H., and Russell M.E. Echocardiography improves detection of rejection after heterotopic mouse cardiac transplantation. J. Am. Soc. Echocardiogr. 15 (2002) 1315-1320
114. Nguyen T.K., Nilakantan V., Felix C.C., Khanna A.K., and Pieper G.M. Beneficial effect of a-tocopheryl succinate in rat cardiac transplants. J. Heart Lung Transplant. 25 (2006) 707-715
115. Nilakantan V., Zhou X., Hilton G., Shi Y., Baker J.E., Khanna A.K., and Pieper G.M. Antagonizing reactive oxygen by treatment with a manganese(III) metalloporphyrin-based superoxide dismutase mimetic in cardiac transplants. J. Thorac. Cardiovasc. Surg. 131 (2006) 898-906
116. Pieper G.M., Nilakantan V., Chen M., Zhou J., Khanna A.K., Henderson Jr. J.D., Johnson C.P., Roza A.M., and Szabó. Protective mechanisms of a metalloporphyrinic peroxynitrite decomposition catalyst, WW85, in rat cardiac transplants. J. Pharmacol. Exp. Ther. 314 (2005) 53-60
117. Schulz, R., Dodge, K. L., Lopaschuk, G. D., Clanachan, A. S., Peroxynitrite impairs cardiac contractile function by decreasing cardiac efficiency. Am. J. Physiol. 272 (Heart Circ. Physiol. 41):H1212-H1219, 1997.
118. Ferdinandy P., Danial H., Ambrus I., Rothery R.A., and Schulz R. Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ. Res. 87 (2000) 241-247
119. 3L-nitrotyrosine during acute allograft rejection in an experimental heart transplantation. Transplantation 68 (1999) 1818-1822
120. Szabolcs M.J., Ravalli S., Minanov O., Sciacca R.R., Michler R.E., and Cannon P.J. Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. Transplantation 65 (1998) 804-812
121. Yamaguchi Y., Okabe K., Matsumura F., Akizuki E., Matsuda T., Ohshiro H., Liang J., Yamada S., Mori K., and Ogawa M. Peroxynitrite formation during rat hepatic allograft rejection. Hepatology 29 (1999) 777-784
122. Bourges J.L., Valamanesh F., Torriglia A., Jeanny J.C., Savoldelli M., Renard G., BenEzra D., de Kozak Y., and Behar-Cohen F. Cornea graft endothelial cells undergo apoptosis by way of an alternate (caspase-independent) pathway. Transplantation 78 (2004) 316-323
123. MacMillan-Crow L.A., Cruthirds D.L., Ahki K.M., Sanders P.W., and Thompson J.A. Mitochondrial tyrosine nitration precedes chronic allograft nephropathy. Free Radic. Biol. Med. 31 (2001) 1603-1608
124. Eiserich J.P., Hristova M., Cross C.E., Jones A.D., Freeman B.A., Halliwell B., and van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature (London) 391 (1998) 393-397
125. Murata S., Miniati D.N., Kown M.H., Koransky M.L., Lijkwan M.A., Balsam L.B., and Robbins R.C. Superoxide dismutase mimetic M40401 reduces ischemia-reperfusion injury and graft coronary artery disease in rodent cardiac allografts. Transplantation 78 (2004) 1166-1171
126. Healy D.G., Watson R.W.G., O'Keane C., Egan J.J., McCarthy J.F., Hurley J., Fitzpatrick J., and Wood A.E. Neutrophil transendothelial migration potential predicts rejection severity in human cardiac transplantation. Eur. J. Cardio-Thorac. Surg. 29 (2006) 760-766
127. Egi K., Conrad N.E., Kwan J., Schulze C., Schulz R., and Wilhirt S.M. Inhibition of inducible nitric oxide synthase and superoxide production reduces matrix metalloproteinase-9 activity and restores coronary vasomotor function in rat cardiac allografts. Eur. J. Cardio-Thorac. Surg. 26 (2004) 262-269
128. Akizuki E., Akaike T., Okamoto S., Fujii S., Yamaguchi Y., Ogawa M., and Maeda H. Role of nitric oxide and superoxide in acute cardiac allograft rejection in rats. Proc. Soc. Exp. Biol. Med. 225 (2000) 151-159
129. Ma N., Szabolcs M.J., Sun J., Albala A., Sciacca R.R., Zhong M., Edwards N., and Cannon P.J. The effect of selective inhibition of cyclooxygenase (COX)-2 on acute cardiac allograft rejection. Transplantation 74 (2002) 1528-1534
130. Liu Y., Son N.H., Szabolcs M.J., Ma N., Sciacca R.R., Albala A., Edwards N., and Cannon P.J. Effects of inhibition of poly(adenosine diphosphate-ribose) synthase on acute cardiac allograft rejection. Transplantation 78 (2004) 668-674
131. Hoffman R.A., Langrehr J.M., Wren S.M., Dull K.E., Ildstad S.T., McCarthy S.A., and Simmons R.L. Characterization of the immunosuppressive effects of nitric oxide in graft vs. host disease. J. Immunol. 151 (1993) 1508-1518
132. Allione A., Bernabei P., Bosticardo M., Ariotti S., Forni G., and Novelli F. Nitric oxide suppresses human T lymphocyte proliferation through IFN-g-dependent and IFN-g-independent induction of apoptosis. J. Immunol. 163 (1999) 4182-4191
133. Van der Veen R.C., Dietlin T.A., Pen L., and Gray J.D. Nitric oxide inhibits the proliferation of T-helper 1 and 2 lymphocytes without reduction in cytokine secretion. Cell. Immunol. 193 (1999) 194-201
134. Van der Veen R.C., Dietlin T.A., Pen L., Gray J.D., and Hofman F.M. Antigen presentation to Th1 but not Th2 cells by macrophages results in nitric oxide production and inhibition of T cell proliferation: interferon-g is essential but not sufficient. Cell. Immunol. 206 (2000) 125-135
135. Holán V., Krulová M., Zajícová A., and Pindjáková J. Nitric oxide as a regulatory and effector molecule in the immune system. Mol. Immunol. 38 (2001) 989-995
136. Hoffman R.A., and Ford H.R. Nitric oxide regulation of lymphocyte function. In: Salvemini D., Billiar T.B., and Vodovotz Y. (Eds). Nitric oxide and inflammation (2001), Birkhäuser Verlag, Basel 131-143
137. Blesson S., Thiery J., Gaudin C., Stancou R., Kolb J.P., Moreau J.L., Theze J., Mami-Chouaib F., and Chouaib S. Analysis of the mechanisms of human cytotoxic T lymphocyte response inhibition by NO. Int. Immunol. 14 (2002) 1169-1178
138. Mahidhara R.S., Hoffman R.A., Huang S., Wolf-Johnson A., Vodovotz Y., Simmons R.L., and Billiar T.B. Nitric oxide-mediated inhibition of caspase-dependent T lymphocyte proliferation. J. Leukoc. Biol. 74 (2003) 403-411
139. Taylor-Robinson A.W., Liew F.Y., Severn A., Xu D., McSorley S.J., Garside P., Padron J., and Phillips R.S. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur. J. Immunol. 24 (1994) 980-984
140. Wei X.Q., Charles I.G., Smith A., Ure J., Feng G.J., Huang F.P., Xu D., Muller W., Moncada S., and Liew F.Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375 (1995) 408-411
141. Huang F.P., Niedbala W., Wei X.Q., Xu D., Feng G.J., Robinson J.H., Lam C., and Liew F.Y. Nitric oxide regulates Th1 cell development through inhibition of IL-12 synthesis by macrophages. Eur. J. Immunol. 28 (1998) 4062-4070
142. Niedbala W., Wei X.Q., Piedrafita D., Xu D., and Liew F.Y. Effects of nitric oxide on the induction and differentiation of Th1 cells. Eur. J. Immunol. 29 (1999) 2498-2505
143. Kalyanaraman B., Hogg N., and Pathasarathy S. The biphasic effect of sodium nitroprusside on the oxidative modification of LDL by macrophages. Free Radic. Biol. Med. 15 (1993) 496
144. Pieper G.M., Clarke G.A., and Gross G.J. Stimulatory and inhibitory action of nitric oxide donor agents vs. nitrovasodilators on reactive oxygen production by isolated polymorphonuclear leukocytes. J. Pharmacol. Exp. Ther. 269 (1994) 451-456
145. Lee C., Miura K., Liu X., and Zweier J.L. Biphasic regulation of leukocyte superoxide generation by nitric oxide and peroxynitrite. J. Biol. Chem. 275 (2000) 38965-38972
146. Brito C., Naviliat M., Tiscornia A.C., Vuillier F., Gualco G., Dighiero G., Radi R., and Cayota A.M. Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death. J. Immunol. 162 (1999) 3356-3366
147. Yang X., Ma N., Szabolcs M.J., Zhong J., Athan E., Sciacca R.R., Michler R.E., Anderson G.D., Wiese J.F., Leahy K.M., Gregory S., and Cannon P.J. Upregulation of COX-2 during cardiac allograft rejection. Circulation 101 (2000) 430-438
148. Joshi M.S., Lancaster Jr. J.R., Liu X., and Ferguson Jr. T.B. In situ measurement of nitric oxide production in cardiac isografts and rejecting allografts by an electrochemical method. Nitric Oxide: Biol. Chem. 5 (2001) 561-565
149. Huisman A., Vos I., Van Faassen E.E., Joles J.A., Gröne H.J., Martasek P., Van Zonneveld A.J., Vanin A.F., and Rabelink T.J. Anti-inflammatory effects of tetrahydrobiopterin on early rejection in renal allografts: modulation of inducible nitric oxide synthase. FASEB J. 16 (2002) 1135-11376